Their average twelve-month price target is $13.00, suggesting that the stock has a possible upside of 108.67%. The high price target for SGMO is $16.00 and the   Based on 3 analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $13.00 with a high forecast of  This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the  

SGMO Stock Forecast and Technical Analysis. Hold candidate since 2020-04-07 PDF. Sangamo BioSciences gained 0.30% in the last trading day  Sangamo BioSciences, Inc. (NASDAQ: SGMO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance  26 Mar 2020 Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SGMO  Sangamo Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 16 Mar 2020 (NASDAQ: SGMO) The 36 Months beta value for SGMO stocks is at 2.17, while of the analysts out of 0 who provided ratings for Sangamo 

Sangamo Therapeutics Inc's stock rating is based on fundamental analysis. Don't miss SGMO stock next rating changes

The 6 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating  Sangamo Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SGMO updated stock price target summary. Real time Sangamo Therapeutics (SGMO) stock price quote, stock graph, news & analysis. Sangamo Therapeutics, Inc. Common Stock (SGMO) Analyst Research. SGMO Analyst Ratings. SGMO Stock Forecast and Technical Analysis. Hold candidate since 2020-04-07 PDF. Sangamo BioSciences gained 0.30% in the last trading day  Sangamo BioSciences, Inc. (NASDAQ: SGMO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance  26 Mar 2020 Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SGMO 

View today's stock price, news and analysis for Sangamo Therapeutics Inc. (SGMO). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

Sangamo Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 16 Mar 2020 (NASDAQ: SGMO) The 36 Months beta value for SGMO stocks is at 2.17, while of the analysts out of 0 who provided ratings for Sangamo  Sangamo Therapeutics Inc (SGMO) Stock Quote and detailed dividend history in the field below to get our experts' instant Bull/Bear rating, ranking & more.

Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO) By TheStreet Wire. Apr 26, 2016 10:07 AM EDT. OPINION. These 5 under-$10 biotech stocks are about to break out. By Roberto Pedone.

SGMO Stock Price, Forecast & News (Sangamo Therapeutics) Analyzing Sangamo Therapeutics (NASDAQ:SGMO) stock? View SGMO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Sangamo Therapeutics Inc Stock Quote: SGMO Stock News ... Nov 01, 2019 · SGMO, Sangamo Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Sangamo Therapeutics - SGMO - Stock Price & News | The ... Real time Sangamo Therapeutics (SGMO) stock price quote, stock graph, news & analysis. Real time Sangamo Therapeutics (SGMO) stock price quote, stock graph, news & analysis. Company Rating

Sangamo Therapeutics (NASDAQ:SGMO)‘s stock had its “hold” rating reiterated by Wedbush in a report issued on Wednesday, TipRanks reports. They currently have a $10.00 price target on the biopharmaceutical company’s stock. Wedbush’s price objective would indicate a potential upside of 23.00% from the company’s current price.

SGMO Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for SGMO is 0.24 -- better than merely 17.22% of US stocks. Of note is the ratio of Sangamo Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 15.27% of US stocks have a … Wedbush Reiterates Hold Rating for Sangamo Therapeutics ... Sangamo Therapeutics (NASDAQ:SGMO)‘s stock had its “hold” rating reiterated by Wedbush in a report issued on Wednesday, TipRanks reports. They currently have a $10.00 price target on the biopharmaceutical company’s stock. Wedbush’s price objective would indicate a potential upside of 23.00% from the company’s current price.

Sangamo Therapeutics Inc (SGMO) Quote | Morningstar Learn about SGMO with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on SGMO. SGMO Stock Rating and Data | Sangamo Therapeutics ... SGMO stock rating and analysis - Sangamo Therapeutics : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial Screeners SGMO | Sangamo Therapeutics Inc. Analyst Estimates ... Nov 09, 2019 · Sangamo Therapeutics Inc. analyst estimates by MarketWatch. View SGMO revenue estimates and earnings estimates, as well as analyst recommendations. Sangamo Therapeutics, Inc. (SGMO) Author's Stock Rating ...